News
La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals
La Jolla Pharmaceutical Company, which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, and Tetraphase Pharmaceuticals, Inc. (Nasdaq: TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline...
News
Avid Bioservices Names Nicholas Green as President and Chief Executive Officer
Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, announced that Nicholas Green has been appointed president and...
Clinical Trials
Zealand Pharma announces first patient dosed in Phase 2 trial with long-acting GLP-1 dual agonist in obesity/diabetes
Zealand Pharma announced that the first patient has been dosed in a Phase 2 clinical trial of the long-acting GLP-1/glucagon dual agonist BI 456906, which Zealand has licensed to Boehringer Ingelheim. As part of the license agreement, Zealand will...
News
EPG Health launches Medthority, a medical website personalised for doctors and tailored for pharma
When providing medical information online, enhanced user experience (UX) is the key to delivering real according to digital medical publisher EPG Health. Such is their reason for launching Medthority (www.medthority.com), to replace the company’s previous website for healthcare professionals...
Drug Research
Piramal Pharma Announces Acquisition of Solid Oral Dosage Drug Product Facility in Pennsylvania from G&W Laboratories
Piramal Enterprises Limited’s (PEL) Pharma Solutions business, a contract development and manufacturing organization, has entered into an agreement with G&W Laboratories Inc. to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, PA. According to the...
News
Gemini Bio opens new manufacturing facility in West Sacramento, California
Gemini Bioproducts, LLC, a leading supplier of cell culture reagents and a portfolio company of BelHealth Investment Partners, LLC, a New York-based healthcare private equity firm, announced the opening of a new, state-of-the-art manufacturing facility in West Sacramento, California.
Gemini...
News
WuXi NextCODE Restructures and Becomes Genuity Science
WuXi NextCODE announced plans to restructure its operations and governance in order to best position the company for future growth, ground-breaking offerings for customers, and new collaborations with industry partners. As part of these efforts, effective June 23, 2020,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read